← Leaderboards
Alexander Kornienko
New Mexico Inst Of Mining &Technology
$2,130,051
Attributed
$2,317,051
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $673.6K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,317,051 · 10
By mechanism
R15$1,461,729 · 4
P20$481,322 · 5
R21$374,000 · 1
Top collaborators
- James J La Clair2 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseDrug DiscoveryLeadAnalogIn VitroUnited States National Institutes Of HealthSeriesNovel TherapeuticsCancer TherapyAlkaloidsPreparationEvaluationStructureAntineoplastic AgentsPharmaceutical PreparationsTherapeutic AgentsChemistryIn VivoPharmacophoreMalignant NeoplasmsToxic EffectPublishingCellsResearch Personnel
Grant awards (12)
Tandem Discovery of Drug Leads and Targets via Paal-Knorr reaction$162,125
R21 · FY2020 · GM · contact PI
Acid-Sensitive Glioblastoma Prodrugs Derived from Ophiobolin A$461,764
R15 · FY2019 · CA · contact PI
Tandem Discovery of Drug Leads and Targets via Paal-Knorr reaction$211,875
R21 · FY2019 · GM · contact PI
Mode of Action of the Amaryllidaceae Alkaloid Lycorine-Promising Anticancer Agent$475,519
R15 · FY2014 · CA · contact PI
Heterocyclic Analogues of Podophyllotoxin Accessible by a One-Step Multicomponent$184,146
R15 · FY2009 · CA · contact PI
ELUCIDATION OF THE PANCRATISTATIN CYTOTOXIC PHARMACOPHORE$128,747
P20 · FY2009 · RR · contact PI
ELUCIDATION OF THE PANCRATISTATIN CYTOTOXIC PHARMACOPHORE$126,151
P20 · FY2008 · RR · contact PI
ELUCIDATION OF THE PANCRATISTATIN CYTOTOXIC PHARMACOPHORE$73,220
P20 · FY2007 · RR · contact PI
ELUCIDATION OF THE PANCRATISTATIN CYTOTOXIC PHARMACOPHORE$74,819
P20 · FY2006 · RR · contact PI
Enantiodivergent Synthesis of (+) and (-) Pancratistatin$195,600
R15 · FY2005 · CA
ELUCIDATION OF THE PANCRATISTATIN CYTOTOXIC PHARMACOPHORE$78,385
P20 · FY2005 · RR
Enantiodivergent Synthesis of (+) and (-) Pancratistatin$144,700
R15 · FY2003 · CA